Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

AxioMx
688 E Main St.
Branford, CT 6405
Phone: 203-208-1918
http://www.axiomxinc.com/

AxioMx is applying knowledge gained from the past 15 years of human genome sequencing to produce highly specific recombinant antibodies against the human proteome. The existing antibody development paradigm is too slow and does not always result in consistent, renewable, and quality antibodies. Through proprietary advances in traditional phage display antibody library design, phage display screening and affinity maturation technologies, we rapidly generate antibodies at the required binding and specificity criteria.

Key Contact
Name
Christopher McLeod
Title
CEO
Funding Events

Date
Amount
Type
Investors
11/07/12 $2,000,000 Venture Debt
10/09/13 $2,000,000 Second Round Connecticut Innovations
Elm Street Ventures
Vital Venture Capital


Featured Reading